Volumetric analysis of the terminal ductal lobular unit architecture and cell phenotypes in the human breast.

CP: Developmental biology branching morphogenesis breast light-sheet microscopy mammary gland serial sectioning terminal ductal lobular unit tissue clearing

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 23 03 2024
revised: 20 08 2024
accepted: 20 09 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: aheadofprint

Résumé

The major lactiferous ducts of the human breast branch out and end at terminal ductal lobular units (TDLUs). Despite their functional and clinical importance, the three-dimensional (3D) architecture of TDLUs has remained undetermined. Our quantitative and volumetric imaging of healthy human breast tissue demonstrates that highly branched TDLUs, which exhibit increased proliferation, are uncommon in the resting tissue regardless of donor age, parity, or hormonal contraception. Overall, TDLUs have a consistent shape and branch parameters, and they contain a main subtree that dominates in bifurcation events and exhibits a more duct-like keratin expression pattern. Simulation of TDLU branching morphogenesis in three dimensions suggests that evolutionarily conserved mechanisms regulate mammary gland branching in humans and mice despite their anatomical differences. In all, our data provide structural insight into 3D anatomy and branching of the human breast and exemplify the power of volumetric imaging in gaining a deeper understanding of breast biology.

Identifiants

pubmed: 39368089
pii: S2211-1247(24)01188-4
doi: 10.1016/j.celrep.2024.114837
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114837

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Oona Paavolainen (O)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.

Markus Peurla (M)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.

Leena M Koskinen (LM)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.

Jonna Pohjankukka (J)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.

Kamyab Saberi (K)

VIB Center for Cancer Biology, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.

Ella Tammelin (E)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.

Suvi-Riitta Sulander (SR)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland.

Masi Valkonen (M)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland.

Larissa Mourao (L)

VIB Center for Cancer Biology, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.

Pia Boström (P)

Department of Pathology, Turku University Hospital, 20520 Turku, Finland; University of Turku, 20520 Turku, Finland.

Nina Brück (N)

Department of Pathology, Turku University Hospital, 20520 Turku, Finland; University of Turku, 20520 Turku, Finland.

Pekka Ruusuvuori (P)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland.

Colinda L G J Scheele (CLGJ)

VIB Center for Cancer Biology, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.

Pauliina Hartiala (P)

University of Turku, 20520 Turku, Finland; Department of Plastic and General Surgery, Turku University Hospital, 20520 Turku, Finland; Medicity Research Laboratories and InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland.

Emilia Peuhu (E)

Institute of Biomedicine, Cancer Laboratory FICAN West, University of Turku, 20520 Turku, Finland; Turku Bioscience, University of Turku and Åbo Akademi University, 20520 Turku, Finland. Electronic address: emilia.peuhu@utu.fi.

Classifications MeSH